Bone TransplantationBone BanksBone Marrow TransplantationTransplantation, AutologousBone MarrowBone Marrow CellsBone and BonesBone Marrow PurgingTransplantation, HomologousCombined Modality TherapyHematopoietic Stem Cell TransplantationCyclophosphamideCarmustineBone RemodelingWhole-Body IrradiationLymphoma, Non-HodgkinLiver TransplantationMelphalanBone Marrow DiseasesHematopoietic Stem CellsBone DensityAntineoplastic Combined Chemotherapy ProtocolsStem Cell TransplantationTransplantation ConditioningEtoposideTreatment OutcomeHodgkin DiseaseKidney TransplantationRemission InductionBone ResorptionColony-Forming Units AssayGraft SurvivalHematopoiesisLeukemia, Myeloid, AcuteBusulfanBone Marrow ExaminationCytarabineRecurrenceBone NeoplasmsTime FactorsBone Marrow NeoplasmsGraft vs Host DiseaseThiotepaLeukemiaDrug EvaluationBone DevelopmentHeart TransplantationBone DiseasesSurvival AnalysisLeukemia, MyeloidVincristineBone RegenerationFollow-Up StudiesLung TransplantationMultiple MyelomaActuarial AnalysisPodophyllotoxinPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation, IsogeneicLymphomaCell DifferentiationMesenchymal Stem Cell TransplantationSurvival RateTransplantation ChimeraGranulocyte Colony-Stimulating FactorBone SubstitutesAntigens, CD34Tissue DonorsCells, CulturedRetrospective StudiesDisease-Free SurvivalCell SeparationMice, Inbred C57BLHematologic DiseasesGraft RejectionGranulocyte-Macrophage Colony-Stimulating FactorGranulocytesLeukocyte CountOrgan TransplantationImmunosuppressive AgentsCell TransplantationBone MatrixBlood Cell CountAcute DiseaseAntibodies, MonoclonalPrognosisOsteogenesisFlow CytometryNeuroblastomaTransplantation ImmunologyHematopoietic Stem Cell MobilizationPlatelet CountMyelodysplastic SyndromesBlood Transfusion, AutologousImmunosuppressionT-LymphocytesProspective StudiesDoxorubicinPrednisoneMitoxantrone